Evidence map›Paper›PMID 19446191›Full record

ArticleVaccine2009

Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states.

Mira L Katz, Paul L Reiter, Brenda C Kluhsman, Stephenie Kennedy, Sharon Dwyer, Nancy Schoenberg, Andy Johnson, Gretchen Ely, Karen A Roberto, Eugene J Lengerich and 3 more

Abstract read
In one paragraph

Article in Vaccine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Assessing the burden of HPV-related cancers in Appalachia.Human vaccines & immunotherapeutics · 2013
    Article
  12. Article
  13. HPV vaccination among adolescent females from Appalachia: implications for cervical cancer disparities.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2012
    Article
  14. Article
  15. Assessment of cancer education seminars for Appalachian populations.Journal of cancer education : the official journal of the American Association for Cancer Education · 2012
    Article
  16. Article
  17. Article
  18. Ontario's school-based HPV immunization program: school board assent and parental consent.Canadian journal of public health = Revue canadienne de sante publique
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mira L KatzThe Comprehensive Cancer Center, The Ohio State University, Ohio, USA. mira.katz@osumc.edu
Paul L Reiter
Brenda C Kluhsman
Stephenie Kennedy
Sharon Dwyer
Nancy Schoenberg
Andy Johnson
Gretchen Ely
Karen A Roberto
Eugene J Lengerich
Pamela Brown
Electra D Paskett
Mark Dignan

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI WANCAI YANG · 1985 to 2026
$132.3M
University of Iowa Clinical and Translational Science Program (TL1)UL1RR025755 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$26.3M
Understanding Cancer Information Needs of Appalachian Cancer Survivors/ProvidersU01CA114622 · NCI · UNIVERSITY OF KENTUCKY · PI DIGNAN, MARK B · 2005 to 2010
$6.6M
Structure M.tuberculosis Adenosine Kinase Design Antimicrobial Nucleoside AnalogsR01CA113932 · NCI · UNIVERSITY OF KENTUCKY · PI DIGNAN, MARK B · 2005 to 2009
$2.3M
Patient Activation To Increase Colon Cancer ScreeningK07CA107079 · NCI · OHIO STATE UNIVERSITY · PI KATZ, MIRA L · 2005 to 2009
$783k
NCI NIH HHS CA107079NCI NIH HHS CA113932NCI NIH HHS K07 CA107079NCI NIH HHS P30 CA016058NCI NIH HHS P30CA016058NCI NIH HHS R01 CA113932NCI NIH HHS U01 CA114622NCRR NIH HHS UL1 RR025755
6 · The paper itself

Abstract

Telephone interviews of health department personnel in six states and review of an immunization database from one state were conducted to assess human papillomavirus (HPV) vaccine availability, recommendations, cost, policies, and educational materials in health departments in seven Appalachian states. Most (99.1%) health departments (n=234) reported receiving patient requests for the HPV vaccine, and only two (1%) health departments reported that they did not provide the vaccine for patients. HPV vaccine supply was reported to not meet the demand in 10.5% (24/228) of health departments due to high costs. Level (state, region, county) at which policy about the HPV vaccine was determined, vaccine recommendations, costs, and available educational materials varied among states. This study documented variation in vaccine availability, recommendations, cost, policies, and educational materials in Appalachian health departments that could significantly affect vaccine distribution. Findings highlight the need for more comprehensive and consistent policies that maximize accessibility of the HPV vaccine to women, especially those in underserved areas.

Indexed as

Appalachian RegionFemaleHealth PolicyHumansImmunizationPapillomavirus VaccinesPapillomavirus Vaccines

Identifiers

PMID19446191
PMCPMC2689551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.